CytoSolve provides technology and services towards accelerating drug development using an integrative platform for quantitative modeling of complex molecular pathways. CytoSolve dynamically integrates the computation of smaller models, which can run in parallel across different machines without the need to merge the source codes of the individual models. Using in-silico modeling, it bridges in-vitro testing to human clinical trials with the goal of eliminating animal experimentation.


Posted on

March 9, 2018

Submit a Comment

Your email address will not be published. Required fields are marked *